DKK 117.5
(-0.84%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.46 Billion DKK | -50.37% |
2022 | 2.95 Billion DKK | 65.21% |
2021 | 1.78 Billion DKK | -29.99% |
2020 | 2.55 Billion DKK | 7.49% |
2019 | 2.37 Billion DKK | 1.02% |
2018 | 2.35 Billion DKK | 92.63% |
2017 | 1.22 Billion DKK | -11.14% |
2016 | 1.37 Billion DKK | 12.81% |
2015 | 1.21 Billion DKK | 2.1% |
2014 | 1.19 Billion DKK | -2.53% |
2013 | 1.22 Billion DKK | 325.88% |
2012 | 287.4 Million DKK | -7.08% |
2011 | 309.29 Million DKK | -1.58% |
2010 | 314.27 Million DKK | 4.05% |
2009 | 302.04 Million DKK | 7.79% |
2008 | 280.21 Million DKK | 6.71% |
2007 | 262.59 Million DKK | -8.4% |
2006 | 286.66 Million DKK | -7.19% |
2005 | 308.86 Million DKK | 13.99% |
2004 | 270.96 Million DKK | 3.45% |
2003 | 261.92 Million DKK | -6.21% |
2002 | 279.25 Million DKK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 1.41 Billion DKK | -3.34% |
2024 Q3 | 1.53 Billion DKK | 5.36% |
2024 Q2 | 1.45 Billion DKK | 2.75% |
2023 FY | 1.46 Billion DKK | -50.37% |
2023 Q2 | 1.72 Billion DKK | -40.19% |
2023 Q1 | 2.88 Billion DKK | -2.37% |
2023 Q4 | 1.46 Billion DKK | -7.45% |
2023 Q3 | 1.58 Billion DKK | -8.17% |
2022 Q2 | 2.39 Billion DKK | 0.59% |
2022 Q4 | 2.95 Billion DKK | 11.94% |
2022 Q3 | 2.63 Billion DKK | 10.19% |
2022 FY | 2.95 Billion DKK | 65.21% |
2022 Q1 | 2.38 Billion DKK | 33.17% |
2021 FY | 1.78 Billion DKK | -29.99% |
2021 Q1 | 2.64 Billion DKK | 3.72% |
2021 Q3 | 1.66 Billion DKK | 14.14% |
2021 Q4 | 1.78 Billion DKK | 7.52% |
2021 Q2 | 1.45 Billion DKK | -45.0% |
2020 Q3 | 2.46 Billion DKK | -0.88% |
2020 Q1 | 2.55 Billion DKK | 7.45% |
2020 Q2 | 2.48 Billion DKK | -2.55% |
2020 FY | 2.55 Billion DKK | 7.49% |
2020 Q4 | 2.55 Billion DKK | 3.57% |
2019 Q2 | 2.34 Billion DKK | -1.88% |
2019 FY | 2.37 Billion DKK | 1.02% |
2019 Q1 | 2.38 Billion DKK | 1.53% |
2019 Q4 | 2.37 Billion DKK | 11.5% |
2019 Q3 | 2.13 Billion DKK | -9.05% |
2018 Q4 | 2.35 Billion DKK | -0.55% |
2018 FY | 2.35 Billion DKK | 92.63% |
2018 Q1 | 2.21 Billion DKK | 81.24% |
2018 Q2 | 2.36 Billion DKK | 6.87% |
2018 Q3 | 2.36 Billion DKK | 0.0% |
2017 Q3 | 1.34 Billion DKK | -4.14% |
2017 FY | 1.22 Billion DKK | -11.14% |
2017 Q4 | 1.22 Billion DKK | -9.15% |
2017 Q2 | 1.4 Billion DKK | -8.31% |
2017 Q1 | 1.52 Billion DKK | 11.28% |
2016 Q4 | 1.37 Billion DKK | 7.51% |
2016 Q2 | 1.44 Billion DKK | 8.26% |
2016 Q1 | 1.33 Billion DKK | 9.28% |
2016 Q3 | 1.27 Billion DKK | -11.31% |
2016 FY | 1.37 Billion DKK | 12.81% |
2015 Q3 | 1.31 Billion DKK | -5.96% |
2015 Q1 | 1.28 Billion DKK | 7.38% |
2015 Q4 | 1.21 Billion DKK | -7.02% |
2015 FY | 1.21 Billion DKK | 2.1% |
2015 Q2 | 1.39 Billion DKK | 8.74% |
2014 Q2 | 1.26 Billion DKK | 0.64% |
2014 Q3 | 1.27 Billion DKK | 0.87% |
2014 Q4 | 1.19 Billion DKK | -6.28% |
2014 FY | 1.19 Billion DKK | -2.53% |
2014 Q1 | 1.25 Billion DKK | 2.45% |
2013 Q4 | 1.22 Billion DKK | -4.49% |
2013 FY | 1.22 Billion DKK | 325.88% |
2013 Q1 | 320.9 Million DKK | 11.66% |
2013 Q2 | 1.33 Billion DKK | 315.8% |
2013 Q3 | 1.28 Billion DKK | -3.95% |
2012 FY | 287.4 Million DKK | -7.08% |
2012 Q4 | 287.4 Million DKK | -21.26% |
2012 Q3 | 365 Million DKK | 7.45% |
2012 Q2 | 339.7 Million DKK | -3.0% |
2012 Q1 | 350.2 Million DKK | 13.22% |
2011 FY | 309.29 Million DKK | -1.58% |
2011 Q1 | 367.1 Million DKK | 16.81% |
2011 Q2 | 349.6 Million DKK | -4.77% |
2011 Q3 | 321 Million DKK | -8.18% |
2011 Q4 | 309.29 Million DKK | -3.65% |
2010 Q4 | 314.27 Million DKK | -9.56% |
2010 FY | 314.27 Million DKK | 4.05% |
2010 Q1 | 328.6 Million DKK | 8.79% |
2010 Q3 | 347.5 Million DKK | 0.26% |
2010 Q2 | 346.6 Million DKK | 5.48% |
2009 Q4 | 302.04 Million DKK | 0.0% |
2009 FY | 302.04 Million DKK | 7.79% |
2008 FY | 280.21 Million DKK | 6.71% |
2007 FY | 262.59 Million DKK | -8.4% |
2006 FY | 286.66 Million DKK | -7.19% |
2005 FY | 308.86 Million DKK | 13.99% |
2004 FY | 270.96 Million DKK | 3.45% |
2003 FY | 261.92 Million DKK | -6.21% |
2002 FY | 279.25 Million DKK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
ChemoMetec A/S | 111.35 Million DKK | -1216.487% |
Demant A/S | 21.2 Billion DKK | 93.088% |
GN Store Nord A/S | 21.05 Billion DKK | 93.037% |
Scandinavian Medical Solutions A/S | 89.51 Million DKK | -1537.753% |
ViroGates A/S | 7.54 Million DKK | -19322.364% |